ArticlePolymers2024
Applying pH Modulation to Improve the Thermal Stability of Melamine-Formaldehyde Microcapsules Containing Butyl Stearate as a Phase-Change Material.
Article in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This paper presents a two-stage microencapsulation process that uses pH modulation to enhance the thermal stability of microcapsules that consist of a melamine-formaldehyde (MF) shell and a butyl stearate core. In the first stage, the pH value was modulated between 6.0 and 8.0. Rising the pH value to 8.0 slowed the polycondensation rate, allowing the MF resin with a lower degree of polymerization to migrate to the capsule surface and form a smooth shell. Lowering the pH value to 6.0 accelerated polycondensation. In the second stage, a relatively fast, continuous reduction in the pH value to 5.0 led to further MF polycondensation, hardening the shell. Post-curing at 100 °C prevented shell damage caused by the liquid-gas phase transition of the core material during the process. The microcapsules produced by increasing the pH value to 8.0 twice demonstrated improved thermal stability, with only a minimal overall weight loss of 5% at 300 °C. Significant weight loss was observed between 350 and 400 °C, temperatures at which the methylene bridges in the MF shell undergo thermal degradation. The results from differential scanning calorimetry, electron microscopy, and thermogravimetry analyses confirmed a successful optimization of the microencapsulation, showing that these microcapsules are promising for thermal energy storage and other applications that require high thermal stability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.